Market Cap: $180.95B
Market Cap: $180.95B

Abbott Laboratories ( ABT ) is in the midst of a transformative journey, embracing innovation and strategic expansions that promise to redefine its role in the healthcare industry. This article delves…

Abbott Laboratories ( ABT ) is navigating a transformative phase in its corporate journey, characterized by significant advancements in product offerings and strategic acquisitions. The company's robu…

Abbott Laboratories ( ABT ) is making significant strides in the healthcare sector, particularly in diabetes management, through innovative technologies and strategic acquisitions. The company's recen…

Abbott Laboratories ( ABT ) has consistently demonstrated its commitment to innovation in the healthcare sector, with recent developments that underscore its direct response to pressing health challen…

Abbott Laboratories (Ticker: ABT) is transforming diabetes management with the launch of its Instinct continuous glucose monitoring (CGM) sensor across Europe. This innovative technology integrates se…

Abbott Laboratories (Ticker: ABT) is making waves in the healthcare sector with its recent partnership focus on enhancing diagnostic capabilities. Abbott Partners with ALZpath for Advanced Alzheimer's…

Abbott Laboratories (Ticker: ABT) recently launches its 'Love Without Measure' initiative through its Similac brand, addressing the pressures modern parents face in a social media-driven world. A nati…

Abbott Laboratories (Ticker: ABT) takes a significant step in enhancing diabetes management with the introduction of its Libre Duo and Libre Duo 10 Day continuous monitoring systems for glucose and ke…

Abbott Laboratories (NYSE: ABT) has made a significant impression at the Heart Rhythm Society 2026 conference held in Chicago, presenting groundbreaking findings from multiple clinical trials that und…

Abbott Laboratories announces its intention to acquire Exact Sciences for $21 billion in a major move within the healthcare sector. This acquisition is significant as it represents the largest healthc…
Abbott Laboratories Sets Sights on FDA Submission with Innovative Device Studies Abbott Laboratories is making significant strides in the regulatory pathway for its latest innovative medical device, a…
Abbott Laboratories Expands Leadership in Cancer Diagnostics with Exact Sciences Acquisition Abbott Laboratories is set to enhance its position in the cancer diagnostics arena with its planned acquisi…
Abbott Laboratories Takes Cues from Industry Trends for Innovative Developments In the healthcare landscape, Abbott Laboratories is dynamically navigating through recent developments, emphasizing its…
Abbott Launches Second Annual 'Abbott Dream Team' Initiative in Partnership with Real Madrid Abbott Laboratories, in collaboration with Real Madrid, announces the launch of the second annual 'Abbott D…
Nurturing the Next Generation: Abbott Laboratories' Commitment to Youth Soccer Development Abbott Laboratories embarks on an ambitious initiative in collaboration with famed soccer club Real Madrid, l…
Abbott Laboratories Strengthens Market Position Through Consistent Dividend Strategy Abbott Laboratories positions itself as a stable entity in the healthcare sector, especially amid the current marke…
Confidence Grows Among Investors in Abbott Laboratories Recent data indicates a noteworthy decline in short interest surrounding Abbott Laboratories, a trend that may signal shifting investor sentimen…
Escalating Cartel Violence Spurs Heightened Security Measures in Texas The recent death of notorious Mexican drug lord "El Mencho" ushers in a new wave of violence as rival cartels vie for power, sign…
Abbott reaffirms century-long dividend cadence Abbott Laboratories declares a quarterly common dividend of $0.63 per share, payable May 15, 2026, to shareholders of record at the close of business on…
Volt PFA posts strong 12-month outcomes in global real‑world study Abbott Laboratories is reporting 12‑month data from its multi‑center VOLT‑AF Global IDE study that reinforce the safety and efficacy…
Abbott Laboratories' Commitment to Innovative Healthcare Solutions Amid Market Challenges In the current landscape where healthcare companies are navigating through economic uncertainties, Abbott Labo…
Abbott Laboratories Strengthens Commitment to Global Health Initiatives Abbott Laboratories continues to bolster its commitment to global health, particularly in response to the escalating demands for…
Abbott Laboratories Expands Focus on Innovative Health Solutions Amid Financial Sector Uncertainty In the midst of a turbulent financial landscape shaped by mixed earnings reports from major banks, Ab…
Strengthening Legal Expertise: Great American Media Welcomes Paige Havins Great American Media appoints Paige Havins as its new Deputy General Counsel, set to begin her role on January 12, 2026. With…
Regulatory Scrutiny Surrounds Congressional Investments in Cryptocurrency In recent developments, the intersection of politics and finance becomes increasingly pronounced as members of Congress ramp u…
Texas Takes Action Against Child Care Fraud: A Response to National Scandals In light of recent revelations regarding child care funding fraud in Minnesota, Texas Governor Greg Abbott has launched a c…
Texas Governor Abbott Targets Child Care Funding Fraud: A Call for Accountability In a decisive move, Texas Governor Greg Abbott launches an investigation into potential fraud within the state's Child…
Tragic Homicide Sheds Light on Safety Concerns in the Rio Grande Valley In a shocking incident that has reverberated through the Rio Grande Valley, Eddy Betancourt, a well-known businessman and appoin…
Abbott Laboratories Strengthens Position in Diagnostics Amidst Industry Expansion Abbott Laboratories, a major player in the global diagnostics market, is poised to seize growth opportunities as the d…
Abbott Laboratories Receives FDA Approval for Volt PFA System: A New Era in Atrial Fibrillation Treatment Abbott Laboratories marks a significant milestone as the U.S. Food and Drug Administration (FD…
Innovative Cardiac Imaging Solutions: A New Era in Remote Healthcare In a significant advancement for cardiac care, Ventripoint Diagnostics Ltd. has partnered with the Nisg̱a'a Valley Health Authority…
Political Discourse in Educational Spaces: A Challenge for Student Governance Abbott Laboratories is not just a leader in the healthcare sector; it also finds itself intersecting with larger societal…
Abbott Laboratories Champions Blood Donation through Competitive Initiative Abbott Laboratories continues to play a pivotal role in enhancing public health through its sponsorship of the "We Give Bloo…
Abbott Laboratories Champions Blood Donation Initiatives Amidst Competitive Landscape in Diagnostics In a notable development within the healthcare industry, Abbott Laboratories celebrates the Univers…
Abbott Laboratories Launches New Protein Shakes to Support Muscle Health in Older Adults Abbott Laboratories, a leader in science-based nutrition, takes a significant step toward enhancing muscle heal…
Abbott Laboratories Faces FDA Warning Over Malfunctioning Diabetes Devices Abbott Laboratories confronts a significant challenge as the Food and Drug Administration (FDA) issues a serious warning rega…
Critical Safety Alert: Abbott Laboratories Faces FDA Warning Over Glucose Monitoring Devices Abbott Laboratories is currently at the center of a significant safety alert issued by the Food and Drug Ad…
Texas Governor's Controversial Designation Sparks Backlash from Muslim Leaders Texas Governor Greg Abbott's recent proclamation designating the Council on American-Islamic Relations (CAIR) as a "forei…
Abbott Laboratories: Navigating the Complex Landscape of Healthcare Innovation Abbott Laboratories remains a prominent player in the healthcare sector, actively engaging in research and development ac…
Texas National Guard Returns Amid Immigration Tensions Texas Governor Greg Abbott announces the upcoming return of Texas National Guard troops deployed in Illinois to support federal immigration agent…
Concerns Over Islamist Infiltration Spark National Security Debate A recent report by ISGAP raises alarms about the infiltration of U.S. agencies by the Muslim Brotherhood, with a specific focus on th…
Legal Battle Emerges Over Anti-Muslim Designation in Texas The Council on American-Islamic Relations (CAIR) has filed a federal lawsuit against Texas Governor Greg Abbott, challenging his recent desig…
Abbott Laboratories Expands Cancer Diagnostics Capabilities with Exact Sciences Acquisition Abbott Laboratories announces a significant acquisition, purchasing Exact Sciences Corp for approximately $2…
Texas Takes a Firm Stand Against Radicalism: Implications for Public Health and Safety In a recent proclamation, Texas Governor Greg Abbott designates the Council on American-Islamic Relations (CAIR)…
Abbott Laboratories Faces Rising Short Interest Amid Market Sentiment Abbott Laboratories experiences a notable increase in short interest, with a 4.46% rise reported recently. Currently, there are 20…
Abbott Laboratories and the Future of Health Communication Technology Abbott Laboratories stands at the forefront of medical innovation, leveraging advanced technologies to enhance health outcomes and…
Abbott Laboratories Faces Evolving Landscape in Voting Rights and Public Health In the wake of a recent constitutional amendment in Texas, Abbott Laboratories finds itself at the intersection of publi…
Great American Media’s Faith-Centered Initiative Reflects Core Values Amid National Celebration As America nears its 250th anniversary, Great American Media, under the leadership of CEO Bill Abbott, l…
Abbott Laboratories Faces Increased Short Interest Amid Market Dynamics Abbott Laboratories, a prominent player in the healthcare sector, currently sees a notable uptick in short interest as traders p…
Misty Copeland Foundation Expands Ballet Accessibility Initiatives The Misty Copeland Foundation (MCF), founded by the trailblazing principal ballerina Misty Copeland, is set to significantly broaden…